NEWTREE Co.,LTD
KKRX:2708703,480.00
KRW
-25.00
(-0.71%)
ISIN
KR7270870009
Return %
Stock
S&P 500
1Y
-30.82
14.39
3Y
-39.27
81.42
5Y
-88.18
68.62
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Do-Eon Kim
- Full Time Employees
- 86
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Address
- Seoul South Korea
- IPO Date
- Dec 13, 2018
- Website
- newtree.co.kr
- Similar Companies
- Business
- NEWTREE Co.,LTD is a South Korea-based health and beauty company engaged primarily in the research, development, manufacturing, and commercialization of health functional foods, inner beauty supplements, proprietary functional raw materials, and skincare products. Founded in 2001 and headquartered in Seoul, South Korea, the company utilizes biotechnology to formulate natural-derived bioactive ingredients and finished consumer health products targeted at dermal vitality, anti-aging, weight management, and systemic wellness. The company operates across functional dietary supplements, raw material manufacturing, and cosmeceutical applications. Its core product and brand portfolio includes: the Evercollagen line, comprising oral low-molecular collagen peptide supplements such as Evercollagen In & Up Core, Evercollagen Time Biotin, Evercollagen Black, and Evercollagen Waterfull Ampoule for skin hydration and UV damage protection; the Evercollagen Lab line, offering topical skincare and cosmeceutical formulations; the Gynomaster brand, providing specialized women's health supplements including vaginal probiotics and Gynomaster Arginine; the Pandora brand, delivering body fat reduction and metabolic health products based on Panduratin A fingerroot extracts; the Weegard brand, providing gastrointestinal and gastric mucosal health supplements; and Dr.UN, delivering specialized wellness and health functional formulas. In addition to packaged consumer goods, NEWTREE develops and supplies individually recognized functional raw materials on a business-to-business basis to domestic and international dietary supplement and pharmaceutical manufacturers. In recent developments, NEWTREE has executed strategic business expansions across global markets and product categories. The company secured self-affirmed Generally Recognized as Safe status under United States Food and Drug Administration guidelines for its proprietary low-molecular collagen peptide, facilitating ingredient supply agreements across North America and Europe. Concurrently, NEWTREE expanded its overseas retail presence across Southeast Asian markets, establishing finished product distribution through major health and beauty retail chains including Watsons in Malaysia. Domestically, the company has transitioned its primary distribution mix toward direct-to-consumer digital channels and online marketplaces, reducing reliance on television home shopping networks. Furthermore, NEWTREE broadened its operational scope from ingestible inner beauty into topical dermal solutions through the rollout of its dedicated Evercollagen Lab skincare brand and the launch of expanded targeted nutritional supplements across its Evercollagen and Gynomaster franchises.